Skip to main content

Table 3 Logistic regression analysis between SBP trajectory groups and abnormality for indicators of kidney disease in 2016

From: Unstably controlled systolic blood pressure trajectories are associated with markers for kidney damage in prediabetic population: results from the INDEED cohort study

 

Group 1

Group 2

Group 3

Group 4

Group 5

N (%)

726 (50.3%)

323 (22.3%)

176 (12.1%)

181 (12.5%)

45 (2.8%)

eGFR < 60 ml/min/1.73 m2

 Model 1

0.66 (0.11, 4.01)

1.00

0.92 (0.08, 10.19)

2.71 (0.45, 16.34)

3.65 (0.32, 41.06)

 Model 2

0.41 (0.06, 2.51)

1.00

0.41 (0.04, 4.75)

1.18 (0.18, 7.71)

1.33 (0.11, 16.04)

 Model 3

0.41 (0.07, 2.54)

1.00

0.42 (0.04, 4.88)

1.17 (0.18, 7.66)

1.30 (0.11, 15.87)

Model 4

0.32 (0.04, 2.30)

1.00

0.23 (0.02, 3.07)

0.78 (0.10, 5.99)

0.86 (0.06, 11.36)

 Model 5

0.32 (0.04, 2.35)

1.00

0.18 (0.01, 2.71)

0.61 (0.07, 5.74)

0.73 (0.05, 10.24)

3 mg/mmol ≤ uACR ≤ 30 mg/mmol

 Model 1

0.99 (0.64, 1.52)

1.00

1.67 (1.02, 1.24)*

2.32 (1.52, 3.56)*

1.18 (0.41, 3.41)

 Model 2

0.97 (0.63, 1.51)

1.00

1.62 (0.97, 2.69)

2.26 (1.45, 3.52)*

1.14 (0.39, 3.33)

 Model 3

0.97 (0.62, 1.51)

1.00

1.62 (0.98, 2.69)

2.27 (1.46, 3.54)*

1.13 (0.39, 3.32)

 Model 4

0.90 (0.57, 1.42)

1.00

1.55 (0.90, 2.65)

2.22 (1.38, 3.57)*

1.23 (0.41, 3.71)

 Model 5

0.90 (0.57, 1.43)

1.00

1.59 (0.92, 2.74)

2.29 (1.40, 3.77)*

1.27 (0.42, 3.88)

uACR ≥ 30 mg/mmol

 Model 1

0.79 (0.51, 1.24)

1.00

1.02 (0.61, 1.69)

1.68 (1.06, 2.64)*

(0.59 (0.20, 1.71)

 Model 2

0.76 (0.48, 1.20)

1.00

0.95 (0.56, 1.60)

1.58 (0.98, 2.52)

0.54 (0.18, 1.59)

 Model 3

0.76 (0.48, 1.20)

1.00

0.95 (0.56, 1.61)

1.58 (0.99, 2.54)

0.53 (0.18, 1.58)

 Model 4

0.72 (0.45, 1.17)

1.00

0.90 (0.52, 1.58)

1.65 (0.99, 2.73)

0.58 (0.19, 1.75)

 Model 5

0.73 (0.45, 1.18)

1.00

0.93 (0.53, 1.64)

1.74 (1.03, 2.93)*

0.61 (0.20, 1.86)

Orm > P75 (Orm = 21.27 mg/L)

 Model 1

1.28 (0.93, 2.25)

1.00

1.79 (1.18, 2.73)*

1.63 (1.07, 2.49)*

3.63 (2.17, 6.08)*

 Model 2

1.31 (0.94, 1.83)

1.00

1.94 (1.25, 3.01)*

1.76 (1.14, 2.73)*

3.02 (1.53, 5.95)*

 Model 3

1.31 (0.94, 1.83)

1.00

1.94 (1.25, 3.02)*

1.76 (1.14, 2.73)*

3.05 (1.54, 6.01)*

 Model 4

1.29 (0.92, 1.82)

1.00

1.97 (1.25, 3.10)*

1.61 (1.02, 2.54)*

3.13 (1.56, 6.27)*

 Model 5

1.27 (0.90, 1.80)

1.00

1.92 (1.21, 3.05)*

1.53 (0.95, 2.46)

2.92 (1.44, 5.94)*

α 1MG > P75 (α 1MG = 29.75 mg/L)

Model 1

1.40 (1.02, 1.93)*

1.00

1.64 (1.07, 2.51)*

1.45 (0.94, 2.23)

3.02 (1.57, 5.97)*

 Model 2

1.33 (0.95, 1.85)

1.00

1.56 (0.99, 2.44)

1.40 (0.89, 2.20)

2.95 (1.48, 5.84)*

 Model 3

1.33 (0.95, 1.85)

1.00

1.56 (0.99, 2.44)

1.39 (0.89, 2.19)

2.92 (1.47, 5.79)*

 Model 4

1.31 (0.93, 1.85)

1.00

1.52 (0.96, 2.43)

1.31 (0.83, 2.09)

2.96 (1.47, 5.95)*

 Model 5

1.31 (0.92, 1.85)

1.00

1.53 (0.96, 2.45)

1.31 (0.81, 2.13)

2.91 (1.43, 5.94)*

TRF > P75 (TRF = 3.83 mg/L)

 Model 1

1.39 (0.99, 1.95)

1.00

2.28 (1.49, 3.50)*

2.61 (1.72, 3.97)*

4.56 (2.37, 8.75)*

 Model 2

1.43 (1.02, 2.02)*

1.00

2.46 (1.58, 3.84)*

2.80 (1.82, 4.32)*

5.04 (2.58, 9.86)*

 Model 3

1.44 (1.02, 2.02)*

1.00

2.47 (1.58, 3.86)*

2.80 (1.81, 4.32)*

5.09 (2.60, 9.96)*

 Model 4

1.34 (0.94, 1.91)

1.00

2.48 (1.57, 3.93)*

2.50 (1.60, 3.92)*

5.28 (2.65, 10.55)*

 Model 5

1.33 (0.93, 1.89)

1.00

2.46 (1.54, 3.92)*

2.42 (1.51, 3.87)*

5.08 (2.51, 10.27)*

  1. Group 1: moderate-stable group; group 2: low-stable group; group 3: moderate-increasing group; group 4: moderate-decreasing group; group 5: high-stable group
  2. Model 1: no adjustment;
  3. Model 2: adjusted for age, gender;
  4. Model 3: further adjusted for history of myocardial infarction, stroke, cancer;
  5. Model 4: further adjusted for education, physics, smoking status, drinking status, salt habit, triglyceride, total cholesterol, body mass index, LDL, HDL, hsCRP;
  6. Model 5: further adjusted for antihypertensive, hypoglycemic, lipid-lowering drug;
  7. eGFR estimated glomerular filtration rate, α1MG Urinary α1-microglobulin, TRF Transferrinuria, Orm Urinary α1-acid glycoprotein, uACR urinary albumin creatinine ratio